# A Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Adult Subjects

> **NCT05737069** · PHASE1 · COMPLETED · sponsor: **HALEON** · enrollment: 84 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Ibuprofen arginine granules 400 mg
- **DRUG:** Ibuprofen arginine granules 400 mg (Spedifen)

## Key facts

- **NCT ID:** NCT05737069
- **Lead sponsor:** HALEON
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-19
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737069, "A Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05737069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*